Drugmaker Eli Lilly and Co and insurer UnitedHealth Group on Friday said they have partnered to conduct a study of Lilly's COVID-19 antibody treatment bamlanivimab in high-risk Medicare patients.
Lack of a sewage system, open dumping, and contaminated River Kongiti drive outbreak that has killed five and exposed the area's dire infrastructure failure ...
Spanish plasma-based medicines producer Grifols announced that Yimmugo, an innovative intravenous immunoglobulin (IVIg) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback